Trial intelligence / Profile preview

Adacel Revaccination 10 Years After Initial Dose

NCT01439165Phase 4Completed

Sponsor
Sanofi
Start
Nov 2011
Primary completion
Dec 2015
Countries
2
01

Overview

A Phase 4 trial of acellular pertussis vaccine in Tetanus, diphtheria, pertussis, sponsored by Sanofi. Started Nov 2011; status: completed.

02

Drugs

acellular pertussis vaccine
03

Conditions

Tetanusdiphtheriapertussis

Beyond the preview

Go deeper on NCT01439165.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01439165.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call